Follow
Iain McNeish
Iain McNeish
Professor of Oncology, Department of Surgery and Cancer, Imperial College London
Verified email at imperial.ac.uk - Homepage
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
13359*2016
A Phase 3 trial of Bevacizumab in Ovarian Cancer
TJ Perren, AM Swart, J Pfisterer, JA Ledermann, E Pujade-Lauraine, ...
New England Journal of Medicine 365 (26), 2484-2496, 2011
25112011
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
15682017
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
14822011
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
EM Swisher, KK Lin, AM Oza, CL Scott, H Giordano, J Sun, GE Konecny, ...
The lancet oncology 18 (1), 75-87, 2017
11452017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
11182015
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N Colombo, C Sessa, A Du Bois, J Ledermann, WG McCluggage, ...
Annals of Oncology 30 (5), 672-705, 2019
10272019
“Re-educating” tumor-associated macrophages by targeting NF-κB
T Hagemann, T Lawrence, I McNeish, KA Charles, H Kulbe, ...
The Journal of experimental medicine 205 (6), 1261-1268, 2008
9272008
Paraneoplastic thrombocytosis in ovarian cancer
RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ...
New England Journal of Medicine 366 (7), 610-618, 2012
8282012
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
JCC Hu, RS Coffin, CJ Davis, NJ Graham, N Groves, PJ Guest, ...
Clinical cancer research 12 (22), 6737-6747, 2006
6522006
Interleukin-6 as a therapeutic target in human ovarian cancer
J Coward, H Kulbe, P Chakravarty, D Leader, V Vassileva, DA Leinster, ...
Clinical cancer research 17 (18), 6083-6096, 2011
4482011
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
B Delage, DA Fennell, L Nicholson, I McNeish, NR Lemoine, T Crook, ...
International journal of cancer 126 (12), 2762-2772, 2010
4332010
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
3872017
Copy number signatures and mutational processes in ovarian carcinoma
G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ...
Nature genetics 50 (9), 1262-1270, 2018
3712018
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian …
O Kondrashova, M Nguyen, K Shield-Artin, AV Tinker, NNH Teng, ...
Cancer discovery 7 (9), 984-998, 2017
3532017
New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation
S Vandevyver, L Dejager, J Tuckermann, C Libert
Endocrinology 154 (3), 993-1007, 2013
3372013
Mannose impairs tumour growth and enhances chemotherapy
PS Gonzalez, J O’Prey, S Cardaci, VJA Barthet, J Sakamaki, F Beaumatin, ...
Nature 563 (7733), 719-723, 2018
3332018
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
KK Lin, MI Harrell, AM Oza, A Oaknin, I Ray-Coquard, AV Tinker, ...
Cancer discovery 9 (2), 210-219, 2019
3142019
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
IA McNeish, S Strickland, L Holden, GJS Rustin, M Foskett, MJ Seckl, ...
Journal of Clinical Oncology 20 (7), 1838-1844, 2002
3132002
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
3062015
The system can't perform the operation now. Try again later.
Articles 1–20